Diaceutics Share Price (DXRX)

Show Chart Filters
Time period:
Moving Average:
Compare to:
Price 117.50on 17-01-2020 at 16:30:00
Change -2.00 -1.67%
Buy 120.00
Sell 115.00
Buy / Sell DXRX Shares
Sponsored Financial Content
Last Trade: Sell 2,281 at 115.25p
Day's Volume: 21,187
Last Close: 119.50p
Open: 119.50p
Day's Range 117.50p - 119.50p
52wk Range: 82.00p - 122.50p
Market Capitalisation: £82m
VWAP: 0.00p
Shares in Issue: 70m

Recent Trades History Diaceutics (DXRX)

Buy/Sell Volume Trade Prc Trade Type Trade Time
16:22:49 - 17-Jan-20
09:24:27 - 17-Jan-20
08:50:26 - 17-Jan-20
08:35:54 - 17-Jan-20
08:34:06 - 17-Jan-20
08:30:20 - 17-Jan-20
16:23:17 - 16-Jan-20
Delayed publication
10:53:05 - 16-Jan-20
11:14:42 - 16-Jan-20
Delayed publication
16:30:00 - 14-Jan-20

Share Price History for Diaceutics

Time period:
Date Open High Low Close
16th Jan 2020 (Thu)121.50121.50119.50119.50
15th Jan 2020 (Wed)118.50121.50117.50121.50
14th Jan 2020 (Tue)115.50122.50116.00118.50
13th Jan 2020 (Mon)112.00117.00115.50115.50
10th Jan 2020 (Fri)102.00102.00102.00102.00
9th Jan 2020 (Thu)102.00102.00102.00102.00
8th Jan 2020 (Wed)102.00102.00102.00102.00
7th Jan 2020 (Tue)102.00102.00102.00102.00
6th Jan 2020 (Mon)102.00102.00102.00102.00
3rd Jan 2020 (Fri)102.00102.00102.00102.00
2nd Jan 2020 (Thu)102.00102.00102.00102.00
1st Jan 2020 (Wed)
31st Dec 2019 (Tue)102.00102.00102.00102.00
30th Dec 2019 (Mon)102.00102.00102.00102.00
27th Dec 2019 (Fri)101.50101.50101.50101.50
26th Dec 2019 (Thu)00.000.00101.50
25th Dec 2019 (Wed)101.500.000.00101.50
24th Dec 2019 (Tue)101.50101.50101.50101.50
23rd Dec 2019 (Mon)95.50101.5095.50101.50
20th Dec 2019 (Fri)95.5095.5095.5095.50
19th Dec 2019 (Thu)95.0095.0095.0095.50

News about Diaceutics (DXRX)

Diaceutics upgrades profit outlook on strong finish to year

News - Monday, January 13, 2020

Diaceutics upgraded its profit outlook thanks to 'strong' trading performance in......

Diaceutics posts loss as listing costs weigh; revenue rises 34%

News - Monday, September 09, 2019

Data analytics provider to the pharmaceutical industry Diaceutics posted a first-half loss after rising revenue was offset by one-off IPO costs. Pre-tax losses for the six months through June amounted to £1.97m, compared to losses of £1.17m on-year. Revenue rose 34% to £4.4m, offset by IPO-related costs of £1.4m. Gross profit rose 71% to £3.1m. ' We decided to move to AIM to continue our growth trajectory by developing our product and services offering which is focused on better testing and better treatment in the global pharmaceutical industry,' chief executive Peter Keeling said. 'We have seen good growth since we came to market and continue to work hard on expanding the data lake and increasing our international footprint. ...

FTSE 100 Latest

Login to your account

Forgot Password?

Not Registered